COVID-19 Associated Mucormycosis: Scoping Review Protocol Salman Hussain 1 , Harveen Baxi 2 , Abanoub Riad 1,3 Jitka Klugarová 1,3 , Radim Lí eník 1 , Miloslav Klugar #1,3 1 Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic 2 Independent Researcher, New Delhi, India Department of Public Health, Faculty of Medicine, Masaryk University, 62500 Brno, Czech Republic # Corresponding author Dr. Miloslav Klugar, Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic Email: klugar@med.muni.cz . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 1, 2021. ; https://doi.org/10.1101/2021.05.30.21258068 doi: medRxiv preprint NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.